Lanctôt KL - Search Results

1

Respiratory Syncytial Virus Prophylaxis in Immunocompromised Children: Outcomes From the Canadian RSV Evaluation Study of Palivizumab Registry Over Twelve Seasons (2005-2017).

Paes BA, Saleem M, Li A, Lanctôt KL, Mitchell I; CARESS Investigators. Paes BA, et al. Among authors: lanctot kl. Pediatr Infect Dis J. 2020 Jun;39(6):539-545. doi: 10.1097/INF.0000000000002665. Pediatr Infect Dis J. 2020. PMID: 32235248

2

Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes.

Oh PI, Lanctôt KL, Yoon A, Lee DS, Paes BA, Simmons BS, Parison D, Manzi P; Composs Investigators. Oh PI, et al. Among authors: lanctot kl. Pediatr Infect Dis J. 2002 Jun;21(6):512-8. doi: 10.1097/00006454-200206000-00007. Pediatr Infect Dis J. 2002. PMID: 12182374 Clinical Trial.

3

The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: a Canadian-based analysis.

Lanctôt KL, Masoud ST, Paes BA, Tarride JE, Chiu A, Hui C, Francis PL, Oh PI. Lanctôt KL, et al. Curr Med Res Opin. 2008 Nov;24(11):3223-37. doi: 10.1185/03007990802484234. Epub 2008 Oct 16. Curr Med Res Opin. 2008. PMID: 18928643

4

Risk factors and viruses associated with hospitalization due to lower respiratory tract infections in Canadian Inuit children : a case-control study.

Banerji A, Greenberg D, White LF, Macdonald WA, Saxton A, Thomas E, Sage D, Mamdani M, Lanctôt KL, Mahony JB, Dingle M, Roberts A. Banerji A, et al. Among authors: lanctot kl. Pediatr Infect Dis J. 2009 Aug;28(8):697-701. doi: 10.1097/INF.0b013e31819f1f89. Pediatr Infect Dis J. 2009. PMID: 19461554

5

Comparison of the cost of hospitalization for respiratory syncytial virus disease versus palivizumab prophylaxis in Canadian Inuit infants.

Banerji A, Lanctôt KL, Paes BA, Masoud ST, Tam DY, Macdonald WA, Roberts A. Banerji A, et al. Among authors: lanctot kl. Pediatr Infect Dis J. 2009 Aug;28(8):702-6. doi: 10.1097/INF.0b013e31819df78e. Pediatr Infect Dis J. 2009. PMID: 19461555

6

The cost effectiveness of palivizumab in term Inuit infants in the Eastern Canadian Arctic.

Tam DY, Banerji A, Paes BA, Hui C, Tarride JE, Lanctôt KL. Tam DY, et al. Among authors: lanctot kl. J Med Econ. 2009;12(4):361-70. doi: 10.3111/13696990903442155. J Med Econ. 2009. PMID: 19900071 Free article.

7

Cardiopulmonary fitness is associated with cognitive performance in patients with coronary artery disease.

Swardfager W, Herrmann N, Marzolini S, Saleem M, Kiss A, Shammi P, Oh PI, Lanctôt KL. Swardfager W, et al. Among authors: lanctot kl. J Am Geriatr Soc. 2010 Aug;58(8):1519-25. doi: 10.1111/j.1532-5415.2010.02966.x. Epub 2010 Jul 14. J Am Geriatr Soc. 2010. PMID: 20646102

8

The cost effectiveness of palivizumab: a systematic review of the evidence.

Smart KA, Lanctôt KL, Paes BA. Smart KA, et al. Among authors: lanctot kl. J Med Econ. 2010;13(3):453-63. doi: 10.3111/13696998.2010.499749. J Med Econ. 2010. PMID: 20653398 Free article. Review.

9

Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts.

Herrmann N, Black SE, Li A, Lanctôt KL. Herrmann N, et al. Among authors: lanctot kl. Int Psychogeriatr. 2011 May;23(4):539-45. doi: 10.1017/S1041610210001535. Epub 2010 Sep 20. Int Psychogeriatr. 2011. PMID: 20849673 Clinical Trial.

10

Rebuttal: palivizumab for the prevention of respiratory syncytial virus infection.

Smart KA, Lanctôt KL, Paes BA. Smart KA, et al. Among authors: lanctot kl. Can Fam Physician. 2010 Oct;56(10):988-91. Can Fam Physician. 2010. PMID: 20944037 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters